The Nupsala Podcast Episode 11 | Inside the Joint: How Equine Synovium Responds to iPAAG
https://youtu.be/OWjVWnG5hzU In this episode of the Nupsala Podcast, we’re joined by Dr Jason Lowe, equine veterinarian and Chief Veterinary Officer at Contura, to take a deep dive into his 2024 paper examining the histologic and cytologic response of normal equine joints following injection with 2.5% injectable polyacrylamide hydrogel (iPAAG). With over 30 years of global […]
The Nupsala Podcast Episode 10 | The Joint Organ Concept: Rethinking Canine Osteoarthritis
In this episode of the Nupsala Podcast, we’re joined by Ross Allan BVMS PGCertSAS MRCVS, RCVS Advanced Practitioner in Small Animal Surgery and Clinical Director of Referrals at Pets’n’Vets, Glasgow. Ross shares his approach to managing canine osteoarthritis in first-opinion practice, with a focus on intra-articular diagnostics and therapies, collaborative team-based care, and realistic long-term […]
The Nupsala Podcast Episode 9 | A Practical Vet’s View on Stem Cells: Conversations with Dr Simon Constable
Meg Brady, Nupsala Account Manager, is joined by Dr Simon Constable, Advanced Practitioner in Equine Orthopaedic and Soft Tissue Surgery and owner of Simon Constable Equine Vets in the northwest of England. Simon shares his real-world experience using undifferentiated equine umbilical mesenchymal stem cells across both soft-tissue and early-onset joint cases. He talks through how […]
The Nupsala Podcast Episode 4 Bitesize | Polyacrylamide Hydrogels
The Nupsala Podcast Bite Sized: Polyacrylamide Hydrogels with Greg McGarrell (CEO of Nupsala) & Russell Chandler (Veterinary Orthopaedic Surgeon, dual MSc) This episode was recorded live at VOACON 2025 and is an excerpt from The Nupsala Podcast Episode 4 – The Current Landscape of Intra-Articular Therapy in Small Animals. In this bite-sized episode, Russel and Greg […]
The Nupsala Podcast Episode 4 | The Current Landscape of Intra-Articular Therapy in Small Animals
The Nupsala Podcast Episode 4: The Current Landscape of Intra-Articular Therapy in Small Animals with Greg McGarrell (CEO of Nupsala) & Russell Chandler (Veterinary Orthopaedic Surgeon, dual MSc) This episode was recorded live at VOACON 2025. Russell Chandler and Greg McGarrell discuss intra-articular medications and orthobiologics in the management of canine osteoarthritis, drawing comparisons with current […]
The Nupsala Podcast Episode 2 | Dog Sleep & Pain: The Overlooked Connection with Dr. Lauren Davis
The Nupsala Podcast Episode 2: Dog Sleep & Pain: The Overlooked Connection with Dr. Lauren Davis In this episode, Dr. Lauren Davis (VetRelieve CEO and canine sleep expert) joins Meg Brady to explore the often-overlooked connection between sleep and pain in animals. They unpack the science behind canine sleep, its role in recovery, and practical […]
The Nupsala Podcast Episode 1 | Horstem Ft. Almudena Pradera – CEO of Equicord
The Nupsala Podcast | Episode 1 HorStem Podcast with Almudena Pradera, Founder of Equicord & Equine Vet. Welcome to the very first episode of The Nupsala Podcast! In this episode, we sit down with Almudena Pradera, founder of Equicord, to explore the science behind Horstem, a cutting-edge veterinary stem cell therapy derived from umbilical cord […]
Sleep and Osteoarthritis Webinar
Discover how altering pain perception and increasing behavioural thresholds through sleep management can make a significant impact on your patients’ well-being. Join us for an insightful webinar on “Sleep and Osteoarthritis” with Lauren Davis, Director and Founder of VetRelieve. Find out more at nupsala.com/product/vetrest-duo/
HorStem CPD with Almudena Pradera-Munoz
Nupsala invited Equicord’s chief scientific officer Almudena Pradera-Munoz to speak about Horstem. Almudena is a Veterinary surgeon and holds a PhD in physiology and pharmacology.
Horstem is the only licensed equine MSC and is indicated for the reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis) in horses.
This webinar covers all aspects of what makes Horstem unique, from how the stem cells are harvested, to an in-depth explanation of the mechanism of action once injected. Almudena also discusses indications for use and how it has been developed in a ‘ready-to-use’ format.